-
Study aim
-
Determining the scores of women's orgasmic performance, premature ejaculation performance, sexual desire/arousal in women, erectile dysfunction, delayed ejaculation and determining the levels of LDLc, HDL, testosterone, prolactin and HBA1C in patients with diabetes in the intervention and control groups before and after the intervention.
-
Design
-
Clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 80 patients. A sealed envelope was used for randomization.
-
Settings and conduct
-
This study will be conducted in the field of impotence treatment in Yasouj center. 100-200 mg of ginseng capsules will be investigated on impotence with diabetes. The study was double-blind, where the researchers were blinded to the grouping. The participants, fully aware of the type of intervention but blinded to the grouping, were randomly divided into two groups receiving ginseng and placebo.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
30 to 55 years old
suffering from diabetes
Be sexually active
Exit criteria:
physical disability
Treatment for any sexual dysfunction in the past 6 months
Prescribing Coumadin (warfarin), heparin, daltaparin, enoxaparin or any other anticoagulant treatment
Prescribing levodopa for Parkinson's disease or calcipotriene for psoriasis
Diagnosing high blood pressure and prescribing antihypertensive drugs
Severe renal or hepatic failure
Anatomical anomalies of the reproductive system
Prostate Cancer
Genital surgery
Chronic abuse
Allergy to ginseng
-
Intervention groups
-
1- The intervention group receiving ginseng herbal medicine
2- Control group receiving placebo
-
Main outcome variables
-
Female orgasmic performance, premature ejaculation performance, sexual desire/arousal in women, erectile dysfunction, delayed ejaculation and levels of LDLc, HDL, testosterone and prolactin and HBA1C